Delivery Order SPE2DX22D0010-SPE2D825FCD20

Award Date 12/24/24
Potential Completion Date 12/26/24
Potential Value $1.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,114.05, is for the delivery of METHYLPHENIDATE TD PATCH 30S 20MG, a type of pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of December 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methylphenidate Transdermal Patches (30 per package, 10 mg strength) to support the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,819.36, is a Firm Fixed Price Delivery Order issued under the company's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,048.03 and is for the delivery of methylphenidate transdermal patches. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen maintains a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,775.97 firm fixed-price delivery order contract is for the supply of METHYLPHENIDATE 20 MG/9HR PTCH 30S, a pharmaceutical product. The contract has a completion date of May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,030.92, is for the delivery of METHYLPHENIDATE TD PATCH 30S 20MG, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a period of performance through December 3, 2024. Amerisourcebergen holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Methylphenidate transdermal patches, a medical product used in the treatment of mental health conditions. The contract has a ceiling value of $3,130.02 and a period of performance through February 25, 2025. This award is part of a larger Indefinite Delivery Contract...
This federal contract award, with ID SPE2DX22D0010|SPE2D825FBB43, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,314.04 firm fixed-price delivery order is for the procurement of 4566384646 ! METHYLPHENIDATE TD PATCH 30S 20MG, with a completion date of November 12, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,151.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product, to support military...
This federal contract award with ID SPE2DX22D0010|SPE2D825FBN58 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $2,334.58 firm fixed-price delivery order is for the supply of 4,566,564,031 units of 10mg Methylphenidate Transdermal Patches in 30-count packages. The contract has an ultimate completion date of November 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,265.39 firm-fixed-price delivery order is for the supply of Methylphenidate transdermal patches, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 10, 2024 and does not have a set-aside designation. Amerisourcebergen, the prime contractor, is...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FCD20
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,321.81 and covers the procurement of METHYLPHENIDATE TD PATCH 30S 30MG, a medical supply product. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities.

Generated 3/25/25, 9:46 AM